← Back to Search

Behavioral Intervention

MAAPS Intervention for Autism (MAAPS Trial)

N/A
Recruiting
Led By Cynthia Anderson, PhD, BCBA-D-D
Research Sponsored by May Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Genetic disorder known to be associated with ASD such as Fragile X, Down Syndrome, tuberous sclerosis
Motor disabilities such as cerebral palsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, approximately 6 months after baseline, approximately 9 months after baseline
Awards & highlights

Summary

This trial is testing whether MAAPS, an intervention system for elementary students with autism, improves teacher outcomes and student educational outcomes.

Who is the study for?
This trial is for elementary school children (K-6th grade) with an educational classification of autism spectrum disorder, attending public school in person at least once a week. Their parents/guardians and teachers must consent to participate. Children with motor disabilities like cerebral palsy, genetic disorders associated with ASD, or profound vision/hearing loss cannot join.
What is being tested?
The Modular Approach for Autism Programs in Schools (MAAPS) is being tested to see if it improves teacher strategies and student outcomes compared to usual services. MAAPS uses evidence-based methods tailored to help students with ASD succeed in elementary schools.
What are the potential side effects?
Since MAAPS is an educational intervention system rather than a medical treatment, it does not have physical side effects. However, there may be adjustments needed as teachers and students adapt to the new approach.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a genetic condition linked to autism, like Fragile X or Down Syndrome.
Select...
I have a motor disability like cerebral palsy.
Select...
I have severe vision or hearing loss.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, approximately 6 months after baseline, approximately 9 months after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, approximately 6 months after baseline, approximately 9 months after baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in engaged time measured by Academic Engaged Time (AET)
Change in rating for Teacher Nominated Target Problems (TNTP)
Change in score for Adaptive Behavior Assessment System, Third Edition (ABAS-3)
+4 more
Secondary study objectives
Usage Rating Profile-Intervention, Revised (URP-IR)

Trial Design

2Treatment groups
Active Control
Group I: MAAPSActive Control1 Intervention
Modular intervention system integrating evidence-based strategies to address core and associated features of ASD and ongoing coaching.
Group II: Waitlist controlActive Control1 Intervention
Services as usual.

Find a Location

Who is running the clinical trial?

May InstituteLead Sponsor
2 Previous Clinical Trials
128 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
128 Patients Enrolled for Autism Spectrum Disorder
University of South FloridaOTHER
416 Previous Clinical Trials
188,845 Total Patients Enrolled
12 Trials studying Autism Spectrum Disorder
907 Patients Enrolled for Autism Spectrum Disorder
University of RochesterOTHER
847 Previous Clinical Trials
535,277 Total Patients Enrolled
11 Trials studying Autism Spectrum Disorder
9,469 Patients Enrolled for Autism Spectrum Disorder

Media Library

MAAPS (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04533607 — N/A
Autism Spectrum Disorder Research Study Groups: MAAPS, Waitlist control
Autism Spectrum Disorder Clinical Trial 2023: MAAPS Highlights & Side Effects. Trial Name: NCT04533607 — N/A
MAAPS (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04533607 — N/A
~25 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top